Special Issue "Novel Insights on Cerebrospinal Fluid Research"
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: 31 March 2021.
Interests: immune mediated neuropathies; Neuro-Sjögren; multiple sclerosis; neuroimmuno-oncology; neuroinfectious diseases; neuroimmunology
Interests: psychoneuroimmunology; multiple sclerosis; affective disorders; cerebrospinal fluid research; epigenetics; psychiatric biomarkers
Cerebrospinal fluid (CSF) analysis is an essential diagnostic tool in a high number of neurological and psychiatric diseases. This includes predominantly autoimmune, infectious, and neurodegenerative diseases of the central and peripheral nervous system. However, psychiatrists increasingly are involved in this relevant research topic.
Since 2017, CSF oligoclonal bands have been used as a part of the McDonald criteria to diagnose multiple sclerosis. This new diagnostic approach has led to a relevant change in the sensitivity of the criteria to diagnose multiple sclerosis. In the last two years, several groups have shown that multiple sclerosis can be now diagnosed more frequently at the time of first clinical relapse, underlining the importance of incorporating CSF analysis.
The important role of CSF examination and disease monitoring has arisen in further diseases, including autoimmune encephalitis driven by autoantibodies directed against neuronal structures such as the N-methyl-D-aspartate (NMDA) receptor. Patients with such diseases are treated in both neurology and psychiatry. Still, further experimental research is needed to obtain a better understanding of this severe disease entity.
This Special Issue of Cells is dedicated to the complete experimental research on CSF in neurologic and psychiatric diseases. There is a need to identify new biomarkers, including cellular research for most neurological and psychiatric diseases. We look forward for your contribution to this intensely developing area of research.
Prof. Dr. Thomas Skripuletz
Dr. Alexandra Neyazi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- CSF biomarker
- kappa free light chains (KFLC)
- cellular research
- multiple sclerosis
- autoimmune disease